S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|TG Therapeutics, Inc. Announces Data Presentations at the Upcoming 56th American Society of Hematology Annual Meeting|
|Preliminary Data From Ongoing Phase I/II Dose Escalation Study of TG-1101 (Ublituximab) in Combination With TGR-1202 in Heavily Pre-treated Relapsed/Refractory B-Cell Malignancies Demonstrates Encouraging Clinical Activity and Safety|
|Data From Phase 2 Clinical Trial of TG-1101 (Ublituximab) and Ibrutinib Shows Compelling Clinical Activity in Patients With Previously Treated, High-Risk Chronic Lymphocytic Leukemia (CLL)|
|Asbury Automotive Group, Inc. Elects New Directors to Its Board|
|TG Therapeutics, Inc. Announces Third Quarter 2014 Financial Results and Business Update|
|TG Therapeutics, Inc. to Provide an Update on Its Clinical Programs and Corporate Goals for 2015 at the 33rd Annual J.P. Morgan Healthcare Conference|
|TG Therapeutics Announces Collaboration for a Clinical Trial of TGR-1202 in Combination With Ibrutinib (Imbruvica(R)) for Patients With Select B-Cell Malignancies|
|TG Therapeutics, Inc. Announces Appointment of Kenneth Hoberman to Board of Directors|
|TG Therapeutics, Inc. to Host Conference Call on Third Quarter 2014 Financial Results and Business Update|
|TG Therapeutics, Inc. to Present at the 2014 Deutsche Bank BioFEST Conference|
Click above to view more mutual fund data and stats for tgs - Transportadora de Gas del Sur SA ADR.